Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zetomipzomib in autoimmune hepatitis
NCT05569759Phase 2Completed
- Sponsor
- Kezar Life Sciences
- Start
- May 2023
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zetomipzomib in autoimmune hepatitis (AIH), sponsored by Kezar Life Sciences. Started May 2023; status: completed.
02
Drugs
zetomipzomib
03
Conditions
autoimmune hepatitis (AIH)
Beyond the preview
Go deeper on NCT05569759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05569759.